Navigation Links
Transcriptor Reverse Transcriptase

iptase). This time-consuming, expensive step can be eliminated with Transcriptor Reverse Transcriptase.
  • No need to perform an additional RNase H incubation step after reverse transcription (as is recommended for maximum sensitivity when using a RNase H--mutated reverse transcriptase). This time-consuming, expensive step can be eliminated with Transcriptor Reverse Transcriptase.

  • Efficiently label RNA
    • Transcriptor Reverse Transcriptase efficiently incorporates modified nucleotides such as Cy3-, Cy5-, aminoallyl-, DIG-, and Biotin-dUTP modified nucleotides, making it an important enzyme in, for example, microarray applications.


    Result: Transcriptor Reverse Transcriptase exhibits excellent efficiency for cDNA labeling with Cy3 and Cy5.

    Rely on a multi-purpose enzyme, tested in a wide variety of assays
    • Stringent quality criteria are used during the production and manufacturing of Transcriptor Reverse Transcriptase. Each lot is function-tested with conventional thermal cyclers and the LightCycler Instrument, ensuring functionality in end-point and real-time PCR.
    • Additional specifications (e.g., testing for bioburden) increase the safety level when working with RNA.


    '"/>

    Source:


    Page: All 1 2 3 4 5

    Related biology technology :

    1. Increase the Power and Sensitivity for Your cDNA Synthesis with the New Transcriptor Reverse Transcriptase
    2. Use of Transcriptor Reverse Transcriptase in Microarray Analysis
    3. Properties of Reverse Transcriptases
    4. Reverse transcriptases suitable for one-step RT-PCRb
    5. Reverse transcriptases suitable for two-step RT-PCRd
    6. C. therm. Polymerase for Reverse Transcription in Two-Step RT-PCR
    7. Recombinant HIV Reverse Transcriptase
    8. Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    TAG: Transcriptor Reverse Transcriptase

    (Date:7/30/2015)... Marshall, MN (PRWEB) , ... July 31, 2015 , ... ... Ralco Enrichment Center at the Lyon County Fair to be held August 5-9 in ... more about where their meals come from and how agriculture impacts their daily lives. ...
    (Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
    (Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
    (Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
    Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
    ... Study ... Initiated ... ET --, SOUTH SAN FRANCISCO, Calif., Oct. 24 Monogram,Biosciences, Inc. (Nasdaq: ... Third Quarter Results The Company had revenue of $10.4 million for ...
    ... October 25, 2007 at ... ... (Nasdaq: KERX ), a biopharmaceutical company focused on the,acquisition, development ... life-threatening,diseases, including diabetes and cancer, today announced its results for,the third ...
    ... The Pittsburgh Life Sciences,Greenhouse (PLSG), the ... on a fast track for growth, announced ... Technologies, LLC, a developmental-stage,medical device company, whose ... surgical probe that will alleviate the existing,limitations ...
    Cached Biology Technology:Monogram Announces Third Quarter 2007 Financial Results 2Monogram Announces Third Quarter 2007 Financial Results 3Monogram Announces Third Quarter 2007 Financial Results 4Monogram Announces Third Quarter 2007 Financial Results 5Monogram Announces Third Quarter 2007 Financial Results 6Monogram Announces Third Quarter 2007 Financial Results 7Monogram Announces Third Quarter 2007 Financial Results 8Monogram Announces Third Quarter 2007 Financial Results 9Monogram Announces Third Quarter 2007 Financial Results 10Monogram Announces Third Quarter 2007 Financial Results 11Monogram Announces Third Quarter 2007 Financial Results 12Monogram Announces Third Quarter 2007 Financial Results 13Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 6The PLSG Invests $115,000 in Innovention Technologies, LLC 2
    (Date:7/31/2015)... , Chine, 31 juillet 2015 La ... www.icg-10.org ) sera organisée par le BGI du ... Shenzhen en Chine. La ... son inauguration en 2006, l,ICG est devenue l,une ... le domaine des « omiques » et c,est aussi la ...
    (Date:7/31/2015)... SHENZHEN, China , July 31, 2015 The ... ) will be held by BGI from October 22-25, 2015, in ... The conference is celebrating its 10 th ... become one of the world,s most influential annual meetings in ... enthusiastic, and enjoyable scientific gatherings. ICG-10 focuses ...
    (Date:7/23/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software ... ended June 30, 2015.  Revenue for the ... 33% compared to $6.8 million in the same quarter last ... $0.3 million, or $0.01 per diluted share, which compared to ... period a year ago.  Lower revenue and ...
    Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
    ... CINCINNATIWith the discovery of a RNA nano-scaffold that remains ... of Cincinnati (UC) have overcome another barrier to the ... Dane and Mary Louise Miller Endowed Chair and professor ... of Engineering and Applied Sciences report the construction of ...
    ... drilling rig exploded on April 20, 2010, in the ... planetary sciences at the University of Tennessee, Knoxville, grabbed all ... the Louisiana coast. Engel and dozens of scientists ... they knew would be needed once the oil began spilling ...
    ... of white LED bulbs, it turns out, suppresses melatonin 5 ... Sodium bulbs that give off an orange-yellow light. "Just as ... also be regulations and rules for the pollution stemming from ... University of Haifa. , "White" light bulbs that emit ...
    Cached Biology News:Team finds stable RNA nano-scaffold within virus core 2UT researcher investigates Deepwater Horizon oil spill impact on coast 2Dangers of exposure to 'white' light 2Dangers of exposure to 'white' light 3
    ... anti-freeze environment for enzyme conjugated antibodies and ... viscosity solution at -20C , No ... is convenient , Contains preservatives to ... Protect enzyme conjugates during storage without the ...
    A collection of 42 spots with normal tissues from different organs of C57 mice, rat and human....
    ... voice-coil scanning and positioning system is ... have to be positioned or scanned ... It provides superior responsiveness compared to ... mechanics (X or XY stage) are ...
    Improves spot morphology and DNA binding to the slide resulting in increased hybridization signal. ID Clarifier: Optimized spotting solution for use with SigmaScreen APS Coated Slides for Microarrays...
    Biology Products: